A vs ONT.L
A: A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical diagnostics laboratories worldwide. ONT.L: Oxford Nanopore provides portable and scalable DNA and RNA sequencing technology that enables real-time, high-accuracy analysis of genetic material.
Side-by-side fundamentals
| Metric | A | ONT.L | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $141.11 | £1.15 | |
| Market cap as of 2026-08-06 | $39.9B | n/a | |
| P/E as of 2026-08-06 | 27.94 | n/a | |
| PEG as of 2026-08-06 | 3.55 | n/a | |
| Net margin as of 2026-08-06 | +19.6% | n/a | |
| Gross margin as of 2026-08-06 | +52.9% | n/a | |
| Operating margin as of 2026-08-06 | +21.5% | n/a | |
| ROE as of 2026-08-06 | +20.8% | n/a | |
| ROA as of 2026-08-06 | +11.1% | n/a | |
| Debt / equity as of 2026-08-06 | 0.47 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +9.1% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +0.5% | n/a | |
| Dividend yield as of 2026-08-06 | +0.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-06 | 1.22 | n/a | |
| 1-year return as of 2026-08-05 close | +22.8% | -42.4% | A higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.